Welcome to our dedicated page for Ambarella SEC filings (Ticker: AMBA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ambarella, Inc. filings document regulatory disclosures for a Nasdaq-listed edge AI semiconductor company organized in the Cayman Islands, with ordinary shares trading under AMBA. Recent Form 8-K reports cover quarterly and annual results releases, exhibit filings, and material events tied to the company’s public reporting obligations.
The filing record also includes governance and compensation disclosures, including board appointments, director and officer changes, annual bonus plan approvals, executive compensation targets, and related committee actions. These documents provide formal records of Ambarella’s operating-result announcements, securities registration details, board structure, and executive compensation governance.
Filing snapshot: AMBARELLA INC director and CEO Feng-Ming Wang reported a sale of 4,928 ordinary shares on 09/17/2025 at $79.43 per share. The filing states the sale was to pay tax obligations arising from the vesting of restricted stock units. After the transaction, Mr. Wang beneficially owned 788,929 shares, which the filing notes includes 223 shares purchased under the companys employee stock purchase plan on 09/15/2025.
Filing snapshot: AMBARELLA INC director and CEO Feng-Ming Wang reported a sale of 4,928 ordinary shares on 09/17/2025 at $79.43 per share. The filing states the sale was to pay tax obligations arising from the vesting of restricted stock units. After the transaction, Mr. Wang beneficially owned 788,929 shares, which the filing notes includes 223 shares purchased under the companys employee stock purchase plan on 09/15/2025.
Form 144 filed for Ambarella, Inc. (AMBA): The notice reports a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on 09/19/2025 with an aggregate market value of $84,000. The shares were acquired as performance shares on 03/15/2021. The filer, identified in related sales as Christopher Day, sold common shares on 07/14/2025 (2,907 shares), 09/08/2025 (1,772 shares), 09/17/2025 (361 shares), and 09/18/2025 (829 shares). The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 filed for Ambarella, Inc. (AMBA): The notice reports a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on 09/19/2025 with an aggregate market value of $84,000. The shares were acquired as performance shares on 03/15/2021. The filer, identified in related sales as Christopher Day, sold common shares on 07/14/2025 (2,907 shares), 09/08/2025 (1,772 shares), 09/17/2025 (361 shares), and 09/18/2025 (829 shares). The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice: An insider filing indicates proposed and recent sales of Ambarella Inc. common stock under Rule 144. The notice lists a proposed sale of 829 shares through Morgan Stanley Smith Barney on 09/18/2025 on NASDAQ with an aggregate market value of $68,392.50. Acquisition data show 611 shares received as restricted stock on 09/15/2025 and 218 shares purchased via an Employee Stock Purchase Plan on 03/15/2024. Recent sales by the filer, Christopher Day at the Santa Clara address, total 5,551 shares across four transactions from 07/14/2025 to 09/17/2025 with gross proceeds reported.
Form 144 notice: An insider filing indicates proposed and recent sales of Ambarella Inc. common stock under Rule 144. The notice lists a proposed sale of 829 shares through Morgan Stanley Smith Barney on 09/18/2025 on NASDAQ with an aggregate market value of $68,392.50. Acquisition data show 611 shares received as restricted stock on 09/15/2025 and 218 shares purchased via an Employee Stock Purchase Plan on 03/15/2024. Recent sales by the filer, Christopher Day at the Santa Clara address, total 5,551 shares across four transactions from 07/14/2025 to 09/17/2025 with gross proceeds reported.
Ambarella, Inc. (AMBA) Form 144 notice reports a proposed sale of 8,492 shares of Ambarella common stock through Morgan Stanley Smith Barney LLC. The filer acquired these shares as restricted stock on 06/15/2019. The planned approximate sale date is 09/10/2025 on the NASDAQ, with an aggregate market value reported at $716,894.64. The filing lists 42,689,006 shares outstanding, and indicates no related sales in the past three months. The notice includes the standard representation that the seller is unaware of any undisclosed material adverse information and a signature declaration regarding the accuracy of the notice.
Ambarella, Inc. (AMBA) filed a Form 144 reporting proposed insider sales of common stock. The filing notifies a brokered sale of 1,772 shares with an aggregate market value of $150,620, to be executed approximately on 09/08/2025 on NASDAQ. The seller previously acquired 1,463 restricted shares on 03/15/2021 and 309 restricted shares on 06/15/2022. The filing also discloses two recent open-market sales by the same person: 2,907 shares on 07/14/2025 for $194,289.32 and 342 shares on 06/17/2025 for $17,872.10. The notice includes the signer’s representation that no undisclosed material adverse information is known.
Ambarella, Inc. director Chantelle Y. Breithaupt received an annual grant of 2,498 restricted stock units (RSUs). The grant, approved by the board and effective September 2, 2025, vests in four equal quarterly installments beginning September 15, 2025, and becomes fully vested on September 15, 2026, subject to continued service. After the reported acquisition, Ms. Breithaupt beneficially owned 4,940 ordinary shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on September 4, 2025.
Ambarella director Elizabeth M. Schwarting received an annual restricted stock unit (RSU) award of 2,498 ordinary shares approved by the board, reported as a transaction dated 09/02/2025. The grant has a vesting schedule that vests one-fourth every three months beginning with a vesting start date of 09/15/2025 and becomes fully vested on 09/15/2026, subject to continued service. The Form 4 shows Schwarting beneficially owns 9,978 shares following the grant and the reported price for the award is listed as $0.0, consistent with an equity grant rather than a purchase.
Ambarella, Inc. director Hsiao-Wuen Hon received an annual restricted stock unit (RSU) award of 2,498 ordinary shares, effective September 2, 2025. The filing shows the grant was approved by the Board and reported on Form 4, with 30,776 shares reported as beneficially owned by Mr. Hon after the award. The RSUs vest in four quarterly installments beginning September 15, 2025, with 1/4th of the shares vesting each three months and full vesting on September 15, 2026, subject to continued service. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Ambarella director David Jeffrey Richardson received an annual restricted stock unit (RSU) grant of 2,498 Ordinary Shares approved by the Board, effective September 2, 2025. The grant vests in four equal quarterly installments beginning September 15, 2025, and will be 100% vested on September 15, 2026, subject to continued service. The Form 4 shows 5,029 Ordinary Shares beneficially owned following the reported transaction and 23,281 shares held indirectly via a family trust. The reported grant price is listed as $0.0. The filing was signed on behalf of Mr. Richardson by an attorney-in-fact on September 4, 2025.
Christopher Paisley, a director of Ambarella, Inc. (AMBA), received an annual restricted stock unit (RSU) grant. The Board approved 2,498 RSUs on 09/02/2025. The RSUs vest in four equal quarterly installments beginning on a vesting start date of 09/15/2025 and are scheduled to be fully vested on 09/15/2026, subject to continued service. After the grant, Mr. Paisley beneficially owns 41,779 ordinary shares. The grant was reported on a Form 4 by an attorney-in-fact on behalf of Mr. Paisley.